Data protection Impressum

Newsroom

The Fonds pour l’Innovation et le Futur de Genève (FIF) has awarded CHF 50,000 grants to three academic spin-off projects from Geneva, supporting innovation in medical technology, scientific instrumentation, and gene therapy.

FIF awards grants to three Geneva-based academic spin-offs

29 January 2026

SWISSto12 has secured EUR 73 million in funding from ESA member states to accelerate the development and industrialization of HummingSat, its next-generation compact geostationary satellite platform.

SWISSto12 secures EUR 73 million ESA backing for HummingSat satellite platform

29 January 2026

In this episode of Getting Serious with Woody Wade, Woody sits down with Florence Schürch, Secretary General of SUISSENÉGOCE, the Swiss Trading and Shipping Association representing companies active in commodity trading and the ecosystem that supports them.

Why Switzerland Is a Global Commodity Trading Superhub (A Conversation with Florence Schurch)

29 January 2026

The first stone of the JD7 building has been laid in Neuchâtel, marking a new milestone for the canton’s innovation district and its future microtechnology research infrastructure.

First stone laid for the JD7 building in Neuchâtel

28 January 2026

Sportswear start-up Revario has reached CHF 1 million in sales, marking a key milestone as it prepares to expand beyond Suisse Romande into new Swiss and European markets.

Fribourg-based Revario reaches CHF 1 million turnover milestone

28 January 2026

TOFWERK acquired by Bruker to strengthening applied mass spectrometry capabilities

20 January 2026

Ex Nunc Intelligence has secured USD 2.15 million in pre-seed funding to accelerate the development of its legal intelligence infrastructure, supporting reliable, traceable and confidential AI tools for legal professionals.

Ex Nunc Intelligence raises USD 2.15 million to develop trusted legal AI infrastructure

20 January 2026

Researchers from the Francis Crick Institute and Bern-based AlveoliX have developed the first human lung-on-chip model built entirely from genetically identical cells, opening new perspectives for personalised respiratory disease research.

AlveoliX contributes to first lung-on-chip model using genetically identical human cells

19 January 2026

Geneva-based biotech start-up FluoSphera has raised CHF 1.15 million to expand its human-relevant preclinical testing platform, supporting the shift toward more predictive and non-animal drug development models.

FluoSphera raises CHF 1.15 million to scale human-based preclinical drug testing

19 January 2026

LEM Surgical presented its Dynamis robotic platform at CES 2026, highlighting its clinical deployment in the U.S. and outlining a new development roadmap integrating NVIDIA’s physical AI technologies.

LEM Surgical showcases its Dynamis robotic system and AI roadmap at CES 2026

19 January 2026

1 2 3 4 5 … 154